TY  - GEN
AU  - Naraev,Boris G
AU  - Strosberg,Jonathan R
AU  - Halfdanarson,Thorvardur R
TI  - Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors
SN  - 1423-0232
PY  - 2012///1030
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzenesulfonates
KW  - Cell Differentiation
KW  - ErbB Receptors
KW  - metabolism
KW  - Everolimus
KW  - Histone Deacetylases
KW  - Humans
KW  - Immunologic Factors
KW  - Indazoles
KW  - Indoles
KW  - pharmacology
KW  - Molecular Targeted Therapy
KW  - methods
KW  - Neuroendocrine Tumors
KW  - drug therapy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Pancreatic Neoplasms
KW  - Phenylurea Compounds
KW  - Pyridines
KW  - Pyrimidines
KW  - Pyrroles
KW  - Receptors, Somatostatin
KW  - Sirolimus
KW  - Sorafenib
KW  - Sulfonamides
KW  - Sunitinib
KW  - TOR Serine-Threonine Kinases
KW  - antagonists & inhibitors
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1159/000339539
ER  -